HME-001

N/A

Report date: 2022/06/13 16:28:29
NME

Base Information

Drug NameHME-001
Drug Alias NameHME-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 modulators
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesHua Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHua Medicine Ltd
Active IndicationsN/A
Inactive IndicationsFragile X Syndrome

Other Information

ATC CodeN/A
Related LinksN/A